From: Thromboprophylaxis prescribing among junior doctors: the impact of educational interventions
Parameter Measured | (N) Number of patients included | |||
---|---|---|---|---|
Pre-proforma (N = 25) | Post- proforma (N = 12) | Post- changeover of doctors (N = 28) | Post-teaching (N = 19) | |
Indication(s) for pharmacological VTE prophylaxis present, % (number) | y = 92.0(23) n = 8.0(2) | y = 66.7(8) n = 33.3(4) | y = 96.4(27) n = 3.6(1) | y = 100(19) |
Contraindication(s) for pharmacological VTE prophylaxis present, % (number) | y = 32.0(8) n = 64.0(16) u/n = 4.0(1) | y = 41.7(5) n = 58.3(7) | y = 17.9(5) n = 78.6(22) u/n = 3.6(1) | y = 42.1(8) n = 57.9(11) |
Documentation of risk assessment, % (number) | y = 8.0 %(2) n = 88.0 %(22) u/n = 4.0 %(1) | y = 25.0 %(3) n = 66.7 %(8) u/n = 8.3 %(1) | y = 32.1 %(9) n = 57.1 %(16) u/n = 10.7 %(3) | y = 31.6 %(6) n = 68.4 %(13) |
Information regarding VTE prophylaxis given to patient, % (number) | y = 28.0 %(7) n = 56.0 %(14) u/n = 16.0 %(4) | y = 50.0 %(6) n = 41.7 %(5) u/n = 8.3 %(1) | y = 35.7 %(10) n = 28.6 %(8) u/n = 35.7 %(10) | y = 57.9 %(11) n = 21.1 %(4) u/n = 21.1 %(4) |
Total patients prescribed pharmacological VTE prophylaxis, % (number) | Y = 32(8) N = 68(17) | y = 33.3(4) n = 58.3(7) u/n = 8.3(1) | y = 60.7(17) n = 35.7(10) u/n = 3.6(1) | y = 63.2(12) n = 36.8(7) |
Patients prescribed pharmacological VTE prophylaxis, where indication(s) present and contraindication(s) absent, % (number) | Y = 35.7 %(5) N = 64.3 %(9) (total = 14) | y = 100 %(4) u/n = 20 %(1) (total 5) | y = 81 %(17) n = 19 %(4) (total 21) | y = 81.8 %(9) n = 18.2 %(2) (total 11) |
Patients prescribed pharmacological prophylaxis where contraindication(s) present, % (number) | Y = 25.0(2) N = 75(6) (Total =8) | n = 100(5) (total 5) | n = 100(5) (total 5) | y = 37.5(3) n = 62.5(5) (total 8) |
Adherence to prescribed pharmacological VTE prophylaxis, % (number) | y = 32(8) u/n = 68(17) | y = 25.0(3) n = 8.3(1) u/n and n/a = 66.6(8) | y = 57.1(16) n = 3.6(1) u/n = 39.3(11) | y = 63.2(12) n/a = 36.8(7) |
Correct dose of pharmacological VTE prophylaxis prescribed, % (number) | Y = 20(5) N = 12(3) n/a = 68(17) | y = 33.3(4) n = 66.7(8) | y = 60.7(17) n/a = 39.3(11) | y = 63.2(12) n = 36.8(7) |
How soon after admission pharmacological VTE prophylaxis prescribed, % (number) | <24 h = 16(4) >24 h = 16(4) n/a = 68(17) | <24 h = 33.3(4) u/n and n/a = 66.6(8) | <24 h = 57.1(16) >24 h = 3.6(1) n/a = 39.3(28) | <24 h = 47.4(9) >24 h = 15.8(3) n/a = 36.8(7) |
Type of pharmacological VTE prophlyaxis prescribed, % (number) | Enoxaparin = 32 (8) Unfract.Hep u/n = 68(17) | Enoxaparin = 33.3 (4) None/na = 66.7(8) | Enoxaparin =60.7(17) Unfract Hep 3.6 (1) n/a = 35.7(10) | Enoxaparin = 63.2(12) None/na = 36.8(7) |